SION Q4 2025 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SIONSionna Therapeutics, Inc.

$2B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$247,000

Operating Income

-$24M

Net Income

-$20M

EPS (Diluted)

$-0.46

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$326M

Total Liabilities

$19M

Stockholders' Equity

$307M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$247,000	$0	—
Operating Income	-$24M	-$18M	-30.2%
Net Income	-$20M	-$16M	-29.0%